This indicates that the tumour microenvironment is important for ILC2-mediated cancer immune-surveillance, and in particular the expression of IL-33 by the tumour may allow the activation of ILC2 function, whereas the lack of IL-33 expression would not support these immune cells. Here, IL33 is linked to cancer.